Tyra Biosciences Inc (TYRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -86,113 | -56,245 | -28,147 | -86,481 | -60,910 |
| Depreciation Amortization | 414 | 283 | 143 | 519 | 375 |
| Other Working Capital | -4,205 | -4,404 | -3,010 | -729 | -1,047 |
| Other Operating Activity | 18,386 | 11,228 | 5,556 | 16,917 | 11,398 |
| Operating Cash Flow | $-71,518 | $-49,138 | $-25,458 | $-69,774 | $-50,184 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 38,170 | 52,937 | 32,040 | -97,739 | -104,703 |
| PPE Investments | -84 | -45 | -14 | -664 | -658 |
| Investing Cash Flow | $38,086 | $52,892 | $32,026 | $-98,403 | $-105,361 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 3,417 | 2,770 | 2,187 | 202,557 | 201,851 |
| Common Stock Repurchased | N/A | N/A | N/A | N/A | -420 |
| Other Financing Activity | 0 | 0 | 0 | -420 | 0 |
| Financing Cash Flow | $3,417 | $2,770 | $2,187 | $202,137 | $201,431 |
| Beginning Cash Position | 92,966 | 92,966 | 92,966 | 59,006 | 59,006 |
| End Cash Position | 62,951 | 99,490 | 101,721 | 92,966 | 104,892 |
| Net Cash Flow | $-30,015 | $6,524 | $8,755 | $33,960 | $45,886 |
| Free Cash Flow | |||||
| Operating Cash Flow | -71,518 | -49,138 | -25,458 | -69,774 | -50,184 |
| Capital Expenditure | -84 | -45 | -14 | -664 | -658 |
| Free Cash Flow | -71,602 | -49,183 | -25,472 | -70,438 | -50,842 |